<DOC>
	<DOCNO>NCT02520479</DOCNO>
	<brief_summary>A phase 2 study conduct `` sandwich '' protocol , early RT initial 2 P-CHOP ( Pegaspargase , cyclophosphamide , vincristine , doxorubicin dexamethasone ) , follow two `` consolidation '' cycle , explore appropriate mode combine modality therapy ( CMT ) early stage ENKTL .</brief_summary>
	<brief_title>`` Sandwich '' Chemotherapy With Radiotherapy Newly Diagnosed , Stage IE IIE , ENKTL</brief_title>
	<detailed_description>The extranodal natural killer/T-cell lymphoma ( ENKTL ) show high local systemic failure rate radiotherapy ( RT ) take primary treatment , suggest role chemotherapy ( CT ) add RT disease . However , appropriate mode combine modality therapy ( CMT ) fully defined.We conduct prospective phase II study `` Sandwich '' Pegaspargase , cyclophosphamide , vincristine , doxorubicin dexamethasone ( P-CHOP ) regimen combination radiotherapy.The `` sandwich '' protocol , refer early RT initial 2 cycle P-CHOP follow two `` consolidation '' cycle .</detailed_description>
	<mesh_term>Pegaspargase</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>newly diagnose ENKTL age:1869years Ann Arbor stage IE , stage IIE cervical lymph node involvement lease one measurable lesion receive chemotherapy radiotherapy Eastern CooperativeOncology Group performance status 0 2 . Adequate hematologic function ( eg , white blood cell ≥ 3×10e9/l , neutrophil count ≥1.5×10e9/L , platelet count≥ 100×10e9/L ) , renal function ( eg , serum creatinine≤1.5 mg/dL creatinine clearance ≥50 mL minute ) , hepatic function ( e.g , total bilirubin≤ 2 time upper limit normal aspartate alanine transaminase level ≤ 3 time upper limit normal ) mismatch inclusion criterion systematic central nervous system involvement previous concomitant malignancy coexist medical problem could cause poor compliance study protocol . primary lesion upper respiratory</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>extranodal natural killer/T-cell lymphoma</keyword>
	<keyword>nasal type</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>chemotherapy</keyword>
</DOC>